Cambridge Investment Research Advisors’s Ares Commercial Real Estate ACRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$296K Sell
61,702
-775
-1% -$3.88K ﹤0.01% 3305
2025
Q4
$299K Sell
62,477
-2,700
-4% -$13.1K ﹤0.01% 3208
2025
Q3
$294K Sell
65,177
-2,670
-4% -$12.4K ﹤0.01% 3124
2025
Q2
$324K Sell
67,847
-3,316
-5% -$14.7K ﹤0.01% 2913
2025
Q1
$329K Sell
71,163
-184
-0.3% -$974 ﹤0.01% 2779
2024
Q4
$420K Sell
71,347
-6,618
-8% -$44.6K ﹤0.01% 2572
2024
Q3
$546K Buy
77,965
+79
+0.1% +$567 ﹤0.01% 2336
2024
Q2
$518K Sell
77,886
-38,285
-33% -$265K ﹤0.01% 2271
2024
Q1
$865K Buy
116,171
+3,377
+3% +$29.4K ﹤0.01% 1825
2023
Q4
$1.17M Buy
112,794
+2,130
+2% +$21K 0.01% 1543
2023
Q3
$1.05M Sell
110,664
-1,844
-2% -$19K ﹤0.01% 1539
2023
Q2
$1.14M Buy
112,508
+1,572
+1% +$14.3K 0.01% 1516
2023
Q1
$1.01M Buy
110,936
+6,260
+6% +$68.5K ﹤0.01% 1568
2022
Q4
$1.08M Buy
104,676
+40,129
+62% +$461K 0.01% 1475
2022
Q3
$675K Buy
64,547
+21,623
+50% +$280K ﹤0.01% 1739
2022
Q2
$525K Buy
+42,924
New +$623K ﹤0.01% 1921
2021
Q2
Sell
-10,853
Closed -$149K 3084
2021
Q1
$149K Sell
10,853
-1,840
-14% -$24.1K ﹤0.01% 2699
2020
Q4
$151K Buy
12,693
+1,230
+11% +$13.1K ﹤0.01% 2539
2020
Q3
$105K Sell
11,463
-1,783
-13% -$16.7K ﹤0.01% 2385
2020
Q2
$121K Buy
13,246
+1,289
+11% +$10K ﹤0.01% 2296
2020
Q1
$84K Buy
11,957
+435
+4% +$6.16K ﹤0.01% 2122
2019
Q4
$183K Buy
11,522
+819
+8% +$12.7K ﹤0.01% 2239
2019
Q3
$163K Sell
10,703
-198
-2% -$3.02K ﹤0.01% 2163
2019
Q2
$162K Buy
10,901
+290
+3% +$4.38K ﹤0.01% 2038
2019
Q1
$161K Sell
10,611
-1,229
-10% -$17.9K ﹤0.01% 2123
2018
Q4
$154K Sell
11,840
-855
-7% -$12K ﹤0.01% 1981
2018
Q3
$177K Sell
12,695
-3,937
-24% -$55.8K ﹤0.01% 2076
2018
Q2
$230K Sell
16,632
-2,790
-14% -$37K ﹤0.01% 1913
2018
Q1
$240K Sell
19,422
-3,828
-16% -$48.2K ﹤0.01% 1845
2017
Q4
$300K Buy
+23,250
New +$309K ﹤0.01% 1655

Other funds holding ACRE

Cambridge Investment Research Advisors's ACRE Position: Q1 2026 in Review

Cambridge Investment Research Advisors reduced its Ares Commercial Real Estate (ACRE) stake by 1.2% in Q1 2026, selling an estimated $3.88K and leaving 61,702 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #3305.

Cambridge Investment Research Advisors first reported a position in ACRE in Q4 2017 and has held it in 30 quarters since. The position peaked at $1.17M in Q4 2023. 138 funds tracked by Wall St. Rank hold ACRE as of Q1 2026.

  • Cambridge Investment Research Advisors held 61,702 shares of Ares Commercial Real Estate worth $296K as of Q1 2026.
  • Cambridge Investment Research Advisors sold 775 Ares Commercial Real Estate shares in Q1 2026, an estimated $3.88K.
  • Ares Commercial Real Estate made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #3305 holding.
  • Cambridge Investment Research Advisors first reported a position in Ares Commercial Real Estate in Q4 2017 and has held it in 30 quarters since.
  • Cambridge Investment Research Advisors's Ares Commercial Real Estate position peaked at $1.17M in Q4 2023.
  • 138 funds tracked by Wall St. Rank held Ares Commercial Real Estate as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.